References
- Willemsen AECAB, van Herpen CML. mTOR inhibitor related pulmonary toxicity; incidence even higher. Acta Oncol Epub 2013 Feb 14.
- Iacovelli R, Palazzo A, Mezi S, Morano F, Naso G, Cortesi E. Incidence and risk of pulmonary toxicity in patients treated with mTOR inhibitors for malignancy. A meta-analysis of published trials. Acta Oncol 2012;51:873–9.